Interim report January-March 2009: Promising start of the year

Interim report January-March 2009: Promising start of the year

* Revenues increased by 46% to SEK 126.0 million (86.3)
* Result before tax was SEK 2.9 million (-0.4)
* Result after tax for the period was SEK -0.3 million (-1.7)
* Result per share amounted to SEK -0.06 (-0.06)
* Operating result amounted to SEK 3.3 million (0.7)
* Operating result (EBITA) for the clinics amounted to SEK 16.9 million (12.6)
* Net cash position amounted to 76.2 MSEK (26.7)
* Equity ratio amounted to 70 per cent (65)
* Three new clinics within Service Line Bariatrics have been started in England,
Norway and Egypt

Comments from Per Båtelson, CEO:
“The year has started well, with good profitability in all the Swedish clinics.
Patient intake continues to be good within all customer areas: patients paid for
by public funds under care contracts, insurance patients and individuals paying
privately. Demand for the care services provided by the clinics remained strong
and the ongoing financial crisis and the recession have not been significantly
reflected in a decline in volumes. Organic growth continues to be good with a
few exceptions and several expansion investments are ongoing in clinics that
have reached their capacity ceiling. The largest investment during the period is
constituted by a clinic at Södersjukhuset in Stockholm, which will be started
during the month of May for the treatment of patients with arrhythmia, an
irregular rhythm of the heartbeat. The investment has run according to schedule
and budget and is long-awaited by Swedish patients who find it difficult to
obtain treatment within their County Council. 

The development of the British business within the Dental and Bariatrics areas
is going somewhat slower than expected, primarily due to the fact that the
market for patients paying privately has weakened during the quarter. This means
prioritisation of customers paid for by public funds, above all within primary
care for obesity patients, and a focus on referring general practice dentists
within specialist dental care. Other clinic start-ups are making demands on both
financial and human resources. We have a considerably more aggressive project
portfolio than in the corresponding period in 2008. Within the obesity area
three parallel start-ups are ongoing and all of them are in the early stages. 

Global Health Partner has a strong financial position with a debt-free Parent
Company and a strong cash position. This provides the business with the capacity
to continue its expansion strategy in accordance with set targets. The current
financial crisis, however, provides for a more cautious approach to capital
intensive acquisitions.”

29 April 2009
Gothenburg, Sweden

Per Båtelson
CEO

Queries should be addressed to:

Per Båtelson, CEO		+46-705 95 57 00
Anna Ahlberg, IR		+46-708 55 38 35

Global Health Partner operates specialist clinics that focus on selected
treatment areas (Spine, Dental, Bariatrics and Orthopaedics) using a business
model unique in the Swedish healthcare sector in which leading physicians become
partners and shareholders. Operating clinics with a high patient volume in a
particular treatment area leads to a higher level of efficiency and quality.
This concept of “Quality through Specialisation” is the foundation for the
clinics and Global Health Partner's operations. Global Health Partner's shares
are traded on the Small Cap list at NASDAQ OMX Stockholm under the abbreviation
“GHP.”

Global Health Partner AB (publ) | www.globalhealthpartner.com
Corp. ID No. 556757-1103 | Östra Hamngatan 26-28 | SE-411 09 Gothenburg | Sweden
Tel +46 (0)31-712 53 00 | Fax +46 (0)31-313 13 21

Global Health Partner AB is required to publish the information herein according
to the Swedish Securities Market Act. This information was published on 29 April
2009 at 11.50 a.m. CET.

This is a translation of the Swedish version of the interim report. When in
doubt, the Swedish wording prevails.